Abstract
Anticancer drugs are in high demand and are being encountered among natural products more frequently than in classical pharmaceutical innovations. Their synthesis has thus become relevant, and essential oils are potential raw materials for this endeavour. This chapter will present recent developments and a historical perspective on the synthesis of anticancer drugs from essential oil components.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aggarwal VK (2009) New uses for old building blocks. Nature Chem 1:433–434
Altmann K-H, Pfeiffer B, Arseniyadis S, Pratt BA, Nicolaou KC (2007) The chemistry and biology of epothilones—the wheel keeps turning. Chem Med Chem 2:396–423
Andrews SP, Ball M, Wierschem F, Cleator E, Oliver S, Hogenauer K, Simic O, Antonello A, Hunger U, Smith MD, Ley SV (2007) Total synthesis of five thapsigargins: guaianolide natural products exhibiting sub-nanomolar SERCA inhibition. Chem Eur J 13:5688–5712
Avery MA, Chong WKM, Jennings-Whites C (1992) Stereoselective total synthesis of (+)-artemisinin, the antimalarial constituent of Artemisia annua L. J Am Chem Soc 114:974–979
Breitmaier E (2006) Terpenes; flavors, fragrances, pharmaca, pheromones. Wiley-VCH, Weinheim
Butler MS (2005) Natural products to drugs: natural product derived compounds in clinical trials. Nat Prod Rep 22:162–195
Castoldi D, Caggiano L, Panigada L, Sharon O, Costa AM, Gennari C (2006) A formal total synthesis of eleutherobin using the ring-closing metathesis (RCM) reaction of a densely functionalized diene as the key step: investigation of the unusual kinetically controlled RCM stereochemistry. Chem Eur J 12:51–62
Chen X-T, Bhattacharya SK, Zhou B, Gutteridge CE, Pettus TRR, Danishefsky SJ (1999) The total synthesis of eleutherobin. J Am Chem Soc 121:6563–6579
Constantino MG, Beltrame M Jr, da Silva GVJ, Zukerman-Schpector J (1996) A novel asymmetric total synthesis of (+)-artemisinin. Synth Commun 26:321–329
Corey EJ, Czakó B, Kurti L (2007) Molecules and medicine. Wiley, Hoboken
Cragg GM, Newman DJ, Snader KM (1997) Natural products in drug discovery and development. J Nat Prod 60:52–60
Cragg GM, Grothaus PG, Newman DJ (2009) Impact of natural products on developing new anti-cancer agents. Chem Rev 109:3012–3043
Croteau R, Kutchan TM, Lewis NG (2000) Natural products (secondary metabolites). In: Buchanan B, Gruissem W, Jones R (eds) Biochemistry & molecular biology of plants. American Society of Plant Physiologists, Rockville, pp 1250–1318
Danishefsky SJ (2010) On the potential of natural products in the discovery of pharma leads: a case for reassessment. Nat Prod Rep 27:1114–1116
Dewick PM (2009) Medicinal natural products; abiosynthetic approach, 3rd edn. Wiley, Baffins Lane
Dias DA, Urban S, Roessner U (2012) A historical overview of natural products in drug discovery. Metabolites 2:303–336
Ellis JM, Crimmins MT (2008) Strategies for the total synthesis of C2-C11 cyclized cembranoids. Chem Rev 108:5278–5298
Erman WF (1985) Chemistry of the monoterpenes: an encyclopedic hand book, vol 1–2. Marcel Dekker, New York
Esatbeyoglu T, Huebbe P, Ernst IM, Chin D, Wagner AE, Rimbach G (2012) Curcumin—from molecule to biological function. Angew Chem Int Ed Engl 51:5308–5332
Feher M, Schmidt JM (2003) Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. J Chem Inf Comput Sci 43:218–227
Fellows IM, Kaelin DE Jr, Martin SF (2000) Application of ring-closing metathesis to the formal total synthesis of (+)-FR900482. J Am Chem Soc 122:10781–10787
Fürstner A, de Souza D, Turet L, Fenster MDB, Parra-Rapado L, Wirtz C, Mynott R, Lehmann CW (2007a) Total syntheses of the actin-binding macrolides latrunculin A, B, C, M, Sand 16-epi-Latrunculin B. Chem Eur J 13:115–134
Fürstner A, Kirk D, Fenster MDB, Aissa C, de Souza D, Nevado C, Tuttle T, Thiel W, Muller O (2007b) Latrunculin analogues with improved biological profiles by “diverted total synthesis”: preparation, evaluation, and computational analysis. Chem Eur J 13:135–149
Gao Y, Honzatko RB, Peters RJ (2012) Terpenoid synthase structures: a so far incomplete view of complex catalysis. Nat Prod Rep 29:1153–1175
Gennari C, Castoldi D, Sharon O (2007) Natural Products with taxol-like anti-tumor activity: synthetic approaches to eleutherobin and dictyostatin. Pure Appl Chem 79:173–180
Ghantous A, Gali-Muhtasib H, Vuorela H, Saliba NA, Darwiche N (2010) What made sesquiterpene lactones reach clinical trials. Drug Discov Today 15:668–678
Gordaliza M (2007) Natural products as leads to anti-cancer drugs. Clin Transl Oncol 9:767–776
Guenther E (ed) (1948–1952) Essential oils, vol 1–6. Van Nostrand, New York
Jacoby M (2005) Taxol. Chem Eng News, 83(25)
Johnson DS, Li JJ (2007) The art of drug synthesis. Wiley, Hoboken
Jørgensen L, McKerrall SJ, Kuttruff CA, Ungeheuer F, Felding J, Baran PS (2013) 14-step synthesis of (+)-ingenol from (+)-3-carene. Science 341:878–882
Kupchan SM (1970) Recent advances in the chemistry of terpenoid tumor inhibitors. Pure Appl Chem 21:227–246
Lachance H, Wetzel S, Kumar K, Waldmann H (2012) Charting, navigating, and populating natural product chemical space for drug discovery. J Med Chem 55:5989–6001
Lim HN, Parker KA (2013) Total synthesis of kingianin A. Org Lett 15:398–401
Liu H-J, Yeh W-L, Chew SY (1993) A total synthesis of the antimarial natural product (+)-qinghaosu. Tetrahedron Lett 34:4435–4438
Liu Y-Q, Yang L, Tian X (2007) Podophyllotoxin: current perspectives. Curr Bioact Compd 3:37–66
Maffei ME, Gertsch J, Appendino G (2011) Plant volatiles: production, function and pharmacology. Nat Prod Rep 28:1359–1380
Magauer T, Martin HJ, Mulzer J (2010) Ring-closing metathesis and photo-fries reaction for the construction of the ansamycin antibiotic kendomycin: development of a protecting group free oxidative endgame. Chem Eur J 16:507–519
Magedov IV, Manpadi M, Van slambrouck S, Steelant WFA, Rozhkova E, Przheval’skii NM, Rogelj S, Kornienko A (2007) Discovery and investigation of antiproliferative and apoptosis-inducing properties of new heterocyclic podophyllotoxin analogues accessible by a one-step multicomponent synthesis. J Med Chem 50:5183–5192
Maimone TJ, Baran PS (2007) Modern synthetic efforts toward biologically active terpenes. Nat Chem Biol 3:396–407
Mandel AL, Bellosta V, Curran DP, Cossy J (2009) A versatile route to the tulearin class of macrolactones: synthesis of a stereoisomer of Tulearin A. Org Lett 11:3282–3285
Martin HJ, Pojarliev P, Kählig H, Mulzer J (2001) The 12,13-diol cyclization approach for a truly sereocontrolled total synthesis of epothilone b and the synthesis of a conformationally restrained analogue. Chem Eur J 7:2261–2271
Mishra BB, Tiwari VK (2011) Natural products in drug discovery: clinical evaluations and investigations. In: Tiwari VK, Mishra BB (eds) Natural products in drug discovery: clinical evaluations and investigations, in opportunity, challenge and scope of natural products in medicinal chemistry. Research Signpost, Kerala, pp 1–62
Mondal S, Bandyopadhyay S, Ghosh MK, Mukhopadhyay S, Roy S, Mandal C (2012) Natural products: promising resources for cancer drug discovery. Anti-Cancer Agents Med Chem 12:49–75
Montaser R, Luesch H (2011) Marine natural products: a new wave of drugs? Future Med Chem 3:1475–1489
Mulzer J, Martin HJ (2004) Lessons learned from macrolide synthesis. Chem Rec 3:258–270
Nagar N, Jat RK, Saharan R, Verma S, Sharma D, Bansal K (2011) Podophyllotoxin and their glycosidic derivatives. Pharmacophore 2:124–134
Neidle S, Buss AD, Butler MS (eds) (2010) Natural product chemistry for drug discovery. Royal Society of Chemistry, Milton Road
Newman DJ, Cragg GM, Snader KM (2003) Natural products as sources of new drugs over the period 1981–2002. J Nat Prod 66:1022–1037
Newman DJ (2008) Natural products as leads to potential drugs: an old process or the new hope for drug discovery? J Med Chem 51:2589–2599
Newman DJ, Cragg DM (2012) Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 75:311–335
Nicolaou KC, Montagnon T (2008) Molecules that changed the world. Wiley-VCH, Weinheim
Nicolaou KC, Dai W-M, Guy RK (1994) Chemistry and biology of taxol. Angew Chem Int Ed Engl 33:15–44
Nicolaou KC, Xu J-Y, Kim S, Pfefferkorn J, Ohshima T, Vourloumis D, Hosokawa S (1998) Total synthesis of Sarcodyctins A and B. J Am Chem Soc 120:8661–8673
Nicolaou KC, Chen JS, Dalby SM (2009) From nature to the laboratory and into the clinic. Bioorg Med Chem 17:2290–2303
Nishikawa Y, Kitajima M, Takayama H (2008) First asymmetric total syntheses of cernuane-type Lycopodium Alkaloids, Cernuine, and Cermizine D. Org Lett 10:1987–1990
Ojima I, Chakravarty S, Inoue T, Lin S, He L, Horwitz SB, Kuduk SD, Danishefsky SJ (1999) A common pharmacophore for cytotoxic natural products that stabilize microtubules. Proc Natl Acad Sci U S A 96:4256–4261
Paterson I, Anderson EA (2005) The renaissance of natural products as drug candidates. Science 310:451–453
Pedersen U, Rasmussen PB, Lawesson S-O (1985) Synthesis of naturally occurring curcuminoids and related compounds. Liebigs Ann Chem 1557–1569
Sawadogo WR, Schumacher M, Teiten MH, Cerella C, Dicato M, Diederich M (2013) A survey of marine natural compounds and their derivatives with anti-cancer activity reported in 2011. Molecules 18:3641–3673
Sell CS (2003) A fragrant introduction to terpenoid chemistry. RSC Publishing, Cambridge
Shing TKM, Lee CM, Lo HY (2004) A synthetic approach toward taxol analogs: studies on the construction of the CD ring. Tetrahedron 60:9179–9197
Simmons TL, Andrianasolo E, McPhail K, Flatt P, Gerwick WH (2005) Marine natural products as anti-cancer drugs. Mol Cancer Ther 4:333–342
Srikrishna A, Kumar PP, Reddy TJ (2005) Enantiospecific synthesis of B-Seco-Nortaxanes from two molecules of carvone. Indian J Chem 44B:1430–1436
Tietze LF, Bell HP, Chandrasekhar S (2003) Natural product hybrids as new leads for drug discovery. Angew Chem Int Ed 42:3996–4028
Wender PA, Badham NF, Conway SP, Floreancig PE, Glass TE, Houze JB, Krauss NE, Lee D, Marquess DG, McGrane PL, Meng W, Natchus MG, Shuker AJ, Sutton JC, Taylor RE (1997) The pinene path to Taxanes. 6. A concise stereocontrolled synthesis of taxol. J Am Chem Soc 119:2757–2758
Wessjohann L, Scheid GO, Eichelberger U, Umbreen S (2013) Total synthesis of Epothilone D: the Nerol/Macroaldolization approach. J Org Chem 78:10588–10595
Willot M, Radtke L, Konning D, Frohlich R, Gessner VH, Strohmann C, Christmann M (2009) Total synthesis and absolute configuration of the guaiane sesquiterpene englerin A. Angew Chem Int Ed 48:9105–9108
Wilson RM, Danishefsky SJ (2007) Applications of total synthesis toward the discovery of clinically useful anti-cancer agents. Chem Soc Rev 36:1207–1226
Yin J, Kong L, Wang C, Shi Y, Cai S, Gao S (2013) Biomimetic synthesis of equisetin and (+)-fusarisetin A. Chem Eur J 19:13040–13046
Yusufi M, Banerjee S, Mohammad M, Khatal S, Swamy KV, Khan EM, Aboukameel A, Sarkar FH, Padhye S (2013) Synthesis, characterization and anti-tumor activity of novel thymoquinone analogs against pancreatic cancer. Bioorg Med Chem Lett 23:3101–3104
Zahel M, Keßberg A, Metz P (2013) A short enantioselective total synthesis of (−)-englerin A. Angew Chem Int Ed 52:5390–5392
Zhai J-D, Li D, Long J, Zhang H-L, Lin J-P, Qiu C-J, Zhang Q, Chen Y (2012) Biomimetic semisynthesis of arglabin from parthenolide. J Org Chem 77:7103–7107
Zhang Q, Lu Y, Ding Y, Zhai J, Ji Q, Ma W, Yang M, Fan H, Long J, Tong Z, Shi Y, Jia Y, Han B, Zhang W, Qiu C, Ma X, Li Q, Shi Q, Zhang H, Li D, Zhang J, Lin J, Li LY, Gao Y, Chen Y (2012) Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells. J Med Chem 55:8757–8769
Zhou Q, Chen X, Ma D (2010) Asymmetric, protecting-group-free total synthesis of (−)-englerin A. Angew Chem Int Ed 49:3513–3516
Acknowledgements
The authors wish to thank the following Brazilian agencies for financial support and fellowships; FAPESP (2011/13993-2; 2013/02311-3; 2013/06532-4), CAPES and CNPq. The authors thank all former and present collaborators, for their studied input and hard work on our projects. They also acknowledge the donation of monoterpenes by Firmenich SA.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Brocksom, T., de Oliveira, K., Ferreira, M., Servilha, B. (2015). Essential Oils as Raw Materials in the Synthesis of Anticancer Drugs. In: de Sousa, D. (eds) Bioactive Essential Oils and Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-19144-7_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-19144-7_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-19143-0
Online ISBN: 978-3-319-19144-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)